Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Complement component C5 convertase is a crucial enzyme complex in the complement system that cleaves C5 into C5a and C5b. This cleavage is a critical step in innate immunity, leading to inflammation via C5a and the formation of the membrane attack complex (MAC) via C5b, resulting in pathogen lysis. The enzyme exists in different forms depending on the activation pathway (classical, alternative, or lectin) and its activity is tightly regulated to prevent excessive inflammation.
Cleaves complement protein C5 into C5a and C5b, initiating downstream immune responses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement Component C5 Convertase (C5 convertase).